In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

One Equity Partners invests $75mm in ArthroCare

Executive Summary

Minimally invasive device company ArthroCare raised $75mm through the sale of its 3% Series A preferred stock to One Equity Partners (OEP), the private equity arm of JPMorgan Chase. The shares convert into common at $15 each. Two partners from OEP joined the company's board. Assuming full conversion of the preferred shares, OEP will come out of the transaction owning 15.7% of ArthroCare, a company that manufactures devices based on its Coblation radiofrequency technology.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Other
    • Private Placement

Related Companies